One-month dual antiplatelet therapy after biodegradable-polymer everolimus-eluting stent implantation in diabetic patients at high bleeding risk

European Heart Journal Open 2026 Open access

Read full text
Authors: Leon Gramss, Carlo Andrea Pivato, Andrea Pacchioni, Raffaele Piccolo, Carmine Musto, Gennaro Sardella, Ciro Indolfi, Bernhard Reimers, G Condorelli, Luca Testa, Carlo Briguori, Giulio Stefanini
DOI: 10.1093/ehjopen/oeag034
Cited by: 1
References: 8

Abstract

Primary endpoint was a composite of cardiac death, MI, or definite/probable stent thrombosis. BP-EES: biodegradable-polymer everolimus-eluting stent; CI: confidence interval; CV: cardiovascular; DAPT: dual antiplatelet therapy; HBR: high bleeding risk; HR: hazard ratio; MI: myocardial infarction; PCI: percutaneous coronary intervention; TLF: target lesion failure.For image description, please refer to the figure legend and surrounding text.

Fields of Study & Subjects

Coronary Interventions and Diagnostics Aortic aneurysm repair treatments Peripheral Artery Disease Management

Publication details

Journal / source
European Heart Journal Open
Publisher
Oxford University Press (OUP)
Volume
6
Issue
2
Pages
oeag034–oeag034
Publication date
20 February 2026
Language
EN